These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3337525)

  • 1. [Roferon-A. Canferon-A. Interferon alpha-2A (genetic recombination)].
    Taguchi T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):171-6. PubMed ID: 3337525
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferons and cancer therapy.
    Priestman TJ
    J Pathol; 1983 Nov; 141(3):287-95. PubMed ID: 6363649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTRON A (interferon alfa-2b): clinical overview.
    Spiegel RJ
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
    [No Abstract]   [Full Text] [Related]  

  • 4. How does interferon inhibit tumor growth?
    Gresser I
    Interferon; 1985; 6():93-126. PubMed ID: 2410371
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phase II study of interferon-beta (MR-21) in solid tumors. The Cooperative Study Group of MR-21 in Tumor].
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):942-7. PubMed ID: 3694003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phase I study of interferon-beta (MR-21) in patients with malignant tumors. The Cooperative Study Group of (MR-21) in Tumor].
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):919-27. PubMed ID: 3694000
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 9. Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.
    Laszlo J; Goldstein D; Vugrin D; Hood L; Tso CY
    J Biol Response Mod; 1986 Aug; 5(4):294-9. PubMed ID: 3734845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
    J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
    Grunberg SM; Kempf RA; Itri LM; Venturi CL; Boswell WD; Mitchell MS
    Cancer Treat Rep; 1985 Sep; 69(9):1031-2. PubMed ID: 4028036
    [No Abstract]   [Full Text] [Related]  

  • 13. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
    Ernstoff MS; Fusi S; Kirkwood JM
    J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
    J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon as a treatment tool of cancer].
    Sakurai Y
    Gan No Rinsho; 1983 May; 29(6):579-83. PubMed ID: 6876427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA; Callaghan M; Sarna G
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I study of recombinant human interferon alpha A (Ro 22-8181) in patients with malignant tumors].
    Taguchi T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):456-64. PubMed ID: 4004281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
    Sarna G; Figlin R; Callaghan M
    J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon for treatment of hairy-cell leukemia.
    Med Lett Drugs Ther; 1986 Aug; 28(720):78-9. PubMed ID: 3736496
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Laszlo J
    J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.